In adipocytes, adenylate cyclase is positively regulated by (3-adrenergic agents and negatively regulated by adenosine. Incubation of adipocytes with adenosine deaminase relieves the inhibition of adenylate cyclase by destroying the adenosine that the cells release into the medium. When adipocytes are incubated with adenosine deaminase and the fl-adrenergic agent isoproterenol, most of their ATP is converted to AMP in 5 min. Either isoproterenol or adenosine deaminase alone has little or no effect. In the additional presence of the phosphodiesterase inhibitor 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one (Ro 20-1724) cAMP accumulates instead of AMP. Under these conditions, cAMP represents 40-50% of the total intracellular adenine nucleotides, and ATP only 5%. 
N6-(L-2-phenylisopropyl)adenosine, a deaminase-resistant adenosine agonist, prevents ,B-adrenergic stimulation. 8-(pSulfophenyl)theophylline and 3-isobutyl-1-methylxanthine are both adenosine antagonists that can replace the deaminase in permitting ,B-adrenergic stimulation of adenylate cyclase, but only the latter also inhibits the phosphodiesterase and causes accumulation of cAMP. When the ATP-depleted adipocytes are washed with fresh medium, the nucleoside triphosphate level can be restored within 5 min. The ATP-restored adipocytes can respond rapidly to a second dose of isoproterenol and adenosine antagonist. These findings point out the important role of adenosine in controlling adenylate cyclase activity and the possible involvement of adenylate cyclase in the control of energy flow in rat adipocytes.
The assumption is frequently made that the major pathways for ATP depletion in intact cells are those utilizing the energy in the terminal phosphate bond. The nucleoside triphosphate is the major energy source for a great variety of kinase reactions as well as "ATPase" reactions which lead to molecular motion. The conversion of ATP to cAMP, which is catalyzed by the membrane-bound adenylate cyclase complex, is generally not considered a major pathway for the depletion of ATP.
The binding ofB-adrenergic agents, such as isoproterenol, (4) . Measurements of cAMP were confirmed by the radioimmunoassay method of Harper and Brooker (5). The recovery of 3H-labeled ATP, measured from the point of addition of trichloroacetic acid, was 75% and AMP was the major degradation product. Losses of other nucleotides were not significant. Glycerol release was determined by the method of Garland and Randle (6) .
RESULTS
An understanding of the pathways and mechanisms of energy metabolism in cells requires information on the levels of Abbreviations: iBuMeXan, 3-isobutyl-1-methylxanthine; Ro 20-1724, 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one.
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all adenine nucleotides rather than just ATP. The availability of a HPLC method for nucleotide analysis permits the rapid determination of picomole quantities of ATP, ADP, AMP, and cAMP (Fig. lA) . In untreated control rat adipocytes, the adenine nucteotides are 66.3 + 0.6% ATP, 11.5 + 0.8% ADP, 22.5 ± 1.2% AMP, and <1% cAMP ( Table 1 ). The total adenine nucleotide concentration is a fairly uniform 300 nmol/g of dry weight. Exposure of adipocytes to /3-adrenergic stimulation by epinephrine (5 AuM) or isoproterenol (5 ttM) for 5 min leads to activation of the cAMP-dependent protein kinase. However, cAMP is still <1% of total adenine nucleotides and cannot be measured quantitatively by HPLC. The generation of this "messenger level" of cAMP by adenylate cyclase stimulation can have a tremendous impact on lipolytic and glycogenolytic activity but it has a relatively minor effect on the other adenine nucleotide levels, and the HPLC profile is similar to that of the control (Fig. L4) . Adenylate cyclase has been shown to be subject to regulation by two GTP-binding proteins: Ns, the stimulatory intermediate from the P3-adrenergic receptor, and Ni, the inhibitory intermediate from the adenosine receptor. If the inhibition of adenylate cyclase is reversed by the inclusion of adenosine deaminase, which degrades the endogenous adenosine in the adipocyte incubation medium, there is only a very slight increase in cAMP levels (Table 1 ) and no change from control values for the other nucleotides. In our experiments with this system in adipocytes, we are dealing with three parameters that have the potential to cause major alterations in adenine nucleotide distribution: (i) fB-adrenergic stimulation of adenylate cyclase, (ii) adenosine receptorbased inhibition of adenylate cyclase, and (iii) direct inhibition of cAMP phosphodiesterase activity. Any agent that alters only one of the above parameters does not affect the distribution of adenine nucleotides that we observe by Adipocytes were exposed to the agents at the following concentrations: isoproterenol, 5 ,uM; adenosine deaminase, 1 unit/ml; 8-(p-sulfophenyl)theophylline, 100 .tM; iBuMeXan, 1 mM; Ro 20-1724, 1 mM; epinephrine, 5 AM. In all experiments with adenosine deaminase, the adipocytes were preincubated for 5 min with the enzyme, followed by an additional 5-min incubation with the deaminase and other indicated effectors. At the end of incubation, cells were extracted and the distribution of the adenine nucleotides was determined from integration of the peaks separated by HPLC. Values are those from a typical experiment. *Determined by radioimmunoassay.
HPLC. Thus, treatment of adipocytes with isoproterenol alone, adenosine deaminase alone, or the phosphodiesterase inhibitor Ro 20-1724 alone gives HPLC profiles that are similar to untreated controls (Fig. 1A) . Furthermore, simultaneous treatment with adenosine deaminase (to prevent adenosine inhibition of adenylate cyclase) and Ro 20-1724 (to inhibit cAMP phosphodiesterase) causes no major changes in the HPLC profile of adenine nucleotides. Stimulation by a fadrenergic ageht is an absolute necessity for major changes in adenine nucleotide distribution.
The impact of simultaneous exposure to P-adrenergic stimulation and the reversal of adenosine inhibition is shown in (Fig. 1B) . While ADP remains unchanged, ATP is depleted to less than half of control levels, AMP becomes the predominant nucleotide, and cAMP reaches levels measurable by HPLC. Similar results are obtained if adenosine deaminase is replaced by the adenosine antagonist 8-(p-sulfophenyl)theophylline (100 AM) (Table 1) (7). If, on the other hand, the adenosine agonist, N6-(phenylisopropyl)adenosine (22 AM) (8) is included with the adenosine deaminase in the incubation mixture, the inhibition of adenylate cyclase is not reversed. The depletion of ATP, which results from the simultaneous exposure to P-adrenergic agents and adenosine deaminase, could be the direct result of increased substrate consumption by adenylate cyclase as well as increased ATPutilizing activities that are stimulated by the elevated cAMP level. Involvement of the former pathway is confirmed by adding the compound Ro 20-1724, which inhibits the phosphodiesterase-catalyzed hydrolysis of cAMP to 5'-AMP. Under these conditions-stimulated adenylate cyclase not inhibited by adenosine and inhibited phosphodiesterase cAMP actually becomes the major adenine nucleotide in the cell, while the ATP level falls to only 5% of control (Fig.  1C) . Similar results are obtained when epinephrine replaces isoproterenol or when iBuMeXan, which can function as both an adenosine antagonist and a phosphodiesterase inhibitor (9), is added (Fig. 1D) . These results indicate that the adenylate cyclase-phosphodiesterase couple has the potential to be a major pathway of ATP depletion.
The presence within a cell of cAMP at hundreds of times the level required for saturation of its protein kinase receptor and of ATP at <10% its usual level would seem to be a potentially lethal condition. However, such stressed adipocytes are viable. When these cells are washed repeatedly to remove the various drugs required to reach these extremes, the levels of the nucleotides return to near control levels (Fig. 2) . These cells will still respond to another exposure to isoproterenol and iBuMeXan with cAMP elevation and ATP depletion. There is some increase in AMP during the course of the experiment but there is no evidence of irreversible damage.
It has been suggested that accumulation of intracellular free fatty acids resulting from increased lipolysis can uncouple oxidative phosphorylation and diminish ATP levels in rat adipocytes (10) . Fig. 3A shows that a 15-min incubation with adenosine deaminase increases the rate of ATP depletion in adipocytes by 15%. This correlates with the steady increase of lipolysis (Fig. 3B) . The addition of the ,B-adrenergic agent isoproterenol (5 ,uM) 
DISCUSSION
We present evidence here that ATP can be extensively and reversibly depleted via adenylate cyclase. In the presence of isoproterenol and iBuMeXan, the majority of ATP in adipocytes is converted to cAMP in 5 min. Under these conditions, the cyclic nucleotide can represent 50% of total adenine nucleotides. Recently, using an H2180 incorporation technique, Goldberg and co-workers have demonstrated a rapid turnover of cAMP in platelets under stimulated conditions (11). Though we observe similar phenomena only in the presence of both relief of adenosine inhibition and hormonal stimulation of adenylate cyclase activity in adipocytes, results from both systems point out the considerable potential of adenylate cyclase activity. The resulting cAMP levels are far beyond those that are necessary for cAMP to function as a second messenger in systems such as lipolysis. The reduced rate of lipolysis we observe in these ATP-depleted and cAMP-enriched adipocytes is surprising because lipolysis is stimulated by cAMP and ATP is not required for triacylglycerol hydrolysis. A possible explanation of this phenomenon is that the fully active state of the lipase is a function of continuous phosphorylation and dephosphorylation, a process that requires the maintenance of a certain level of ATP in the cells.
Specific adenosine receptors have been characterized on adipocyte membranes (8) . The fact that the rapid depletion of ATP via adenylate cyclase occurs only in the absence of adenosine demonstrates that adenosine may serve as an important regulator of adenylate cyclase in adipocytes.
